Serial 87038726
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 09 Aug 2024)
What this means for you
Registered since 03 Apr 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87038726
- Registration number
- 5438852
- Mark type
- Design / logo
- Filed
- 16 May 2016
- Published for opposition
- 21 Feb 2017
- Registered
- 03 Apr 2018
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Aug 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Aug 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 03 Apr 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Mar 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Mar 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Apr 2018 — REGISTERED-PRINCIPAL REGISTER
- 27 Feb 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Feb 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Feb 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jan 2018 — USE AMENDMENT FILED